Clinical Trial Update: The Effect of β-Carotene, Vitamin D3 and Zinc on Hyaline Membrane Disease and Feeding Intolerance in Premature Neonates [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of β-Carotene, Vitamin D3, and Zinc on Hyaline Membrane Disease and feeding intolerance in premature neonates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyaline Membrane Disease
• Necrotizing Enterocolitis of Newborn

Drugs mentioned

• Vitamin D3 (Cholecalciferol)
• ZINC (Zinc chloride)
• β-Carotene

Snippet

Sponsor: Indonesia University | Conditions: Hyaline Membrane Disease, Necrotizing Enterocolitis of Newborn | Phase 4 | Status: UNKNOWN